Dev Labtech Venture IPO vs Infinium Pharmachem IPO

Comparison between Dev Labtech Venture IPO and Infinium Pharmachem IPO.

IPO Details

Dev Labtech Venture IPO is a SME Fixed Price IPO proposed to list at BSE SME while Infinium Pharmachem IPO is a SME Fixed Price proposed to list at NSE SME.

	Dev Labtech Venture IPO	Infinium Pharmachem IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price	Fixed Price
Listing At	BSE SME	NSE SME
Lead Managers	Beeline Capital Advisors Pvt.Ltd.	Swastika Investmart Ltd.
Registrar	MUFG Intime India Pvt.Ltd.	Bigshare Services Pvt.Ltd.
Market Maker	Sunflower Broking Pvt.Ltd.	Swastika Investmart Ltd.
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Dev Labtech Venture IPO is up to ₹10.65 Cr whereas the issue size of the Infinium Pharmachem IPO is up to ₹23.99 Cr. The final issue price of Dev Labtech Venture IPO is ₹51.00 per share and of Infinium Pharmachem IPO is ₹135.00 per share.

	Dev Labtech Venture IPO	Infinium Pharmachem IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)	₹51.00 per share	₹135.00 per share
Discount (Retail)	₹0.00 per share	₹0.00 per share
Discount (Employee)		₹13.50 per share
Market Lot Size	2000 shares	1000 shares
Fresh Issue Size	20,88,000 shares	17,81,000 shares
Fresh Issue Size (Amount)	up to ₹10.65 Cr	up to ₹23.99 Cr
OFS Issue Size	0 shares	0 shares
OFS Issue Size (Amount)	up to ₹0.00 Cr	up to ₹0.00 Cr
Issue Size Total	20,88,000 shares	17,81,000 shares
Issue Size Total (Amount)	up to ₹10.65 Cr	up to ₹23.99 Cr

IPO Timetable

Dev Labtech Venture IPO opens on Mar 17, 2023, while Infinium Pharmachem IPO opens on Mar 31, 2023. The closing date of Dev Labtech Venture IPO and Infinium Pharmachem IPO is Mar 21, 2023, and Apr 05, 2023, respectively.

	Dev Labtech Venture IPO	Infinium Pharmachem IPO
Anchor Bid Date
Issue Open	Mar 17, 2023	Mar 31, 2023
Issue Close	Mar 21, 2023	Apr 05, 2023
Basis Of Allotment (Tentative)	Mar 24, 2023	Apr 11, 2023
Initiation of Refunds (Tentative)	Mar 27, 2023	Apr 12, 2023
Credit of Share (Tentative)	Mar 28, 2023	Apr 13, 2023
Listing date (Tentative)	Mar 29, 2023	Apr 17, 2023
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials & KPIs

Dev Labtech Venture IPO P/E ratio is 32.9, as compared to Infinium Pharmachem IPO P/E ratio of 7.83.

Dev Labtech Venture IPO

Infinium Pharmachem IPO

Financials

Dev Labtech Venture Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	711.23	1,178.85	0.04	144.80	123.84	154.05
31-Mar-21	713.73	1,228.11	3.65	148.45	127.50	177.53
31-Mar-22	888.24	2,698.01	43.62	192.07	66.35	122.58
30-Sep-22	1,166.65	966.43	64.12	717.86	232.17	114.52
Amount in ₹ Lakhs

Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-20	2,244.60	3,941.64	93.40	424.74	566.17
31-Mar-21	3,418.27	7,115.37	272.48	702.32	579.47
31-Mar-22	5,899.95	10,005.25	610.64	1,310.22	1,385.01
30-Sep-22	7,075.71	7,985.39	551.01	1,855.77	1,614.71
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

92.66

100

Promoter Shareholding (Post-Issue)

68.01

73.05

P/E Ratio

32.9

7.83

Market Cap

₹42.18 Cr.

₹93.93 Cr.

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Dev Labtech Venture IPO Retail Individual Investors (RII) are offered 10,44,000 shares while in Infinium Pharmachem IPO retail investors are offered 10,44,000 shares. Qualified Institutional Buyers (QIB) are offered in Dev Labtech Venture IPO and in Infinium Pharmachem IPO.

	Dev Labtech Venture IPO	Infinium Pharmachem IPO
Anchor Investor Reserveration
Market Maker Reserveration	1,12,000 shares	94,000 shares
QIB
NII	10,44,000 shares	8,70,000 shares
RII	10,44,000 shares	8,70,000 shares
Employee		41,000 shares
Others
Total	20,88,000 shares	17,81,000 shares

Bids Received (Subscription)

Dev Labtech Venture IPO subscribed 5.47x in total, whereas Infinium Pharmachem IPO subscribed 1.84x.

	Dev Labtech Venture IPO	Infinium Pharmachem IPO
QIB (times)
NII (times)	2.65x	1.80x
Big NII (times)
Small NII (times)
RII (times)	8.24x	1.86x
Employee (times)
Other (times)
Total (times)	5.47x	1.84x

Compare with others

Dev Labtech Venture IPO	Infinium Pharmachem IPO
Sotac Pharmaceuticals IPO	Pattech Fitwell Tube IPO
MOS Utility IPO	Sancode Technologies IPO
Infinium Pharmachem IPO	Exhicon Events Media IPO
Maiden Forgings IPO	Sotac Pharmaceuticals IPO
Command Polymers IPO	MOS Utility IPO
Nirman Agri Genetics IPO	Maiden Forgings IPO
Labelkraft Technologies IPO	Command Polymers IPO
VELS Film International IPO	Dev Labtech Venture IPO
Bright Outdoor Media IPO	Nirman Agri Genetics IPO
Prospect Commodities IPO	Labelkraft Technologies IPO